Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14 Fevereiro 2025 - 7:13PM
Edgar (US Regulatory)
JOINT FILING APPLICATION
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of ABVC BioPharma, Inc. shall be filed on behalf of each
of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
February 14, 2025
LIND GLOBAL FUND II LP
|
|
By:
|
Lind Global Partners II LLC
|
|
its General Partner
|
|
|
By:
|
/s/ Jeff Easton
|
Name:
|
Jeff Easton
|
Title:
|
Managing Member
|
|
|
LIND GLOBAL PARTNERS II LLC
|
|
|
By:
|
/s/ Jeff Easton
|
Name:
|
Jeff Easton
|
Title:
|
Managing Member
|
|
JEFF EASTON
|
|
By:
|
|
|
ABVC BioPharma (NASDAQ:ABVC)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
ABVC BioPharma (NASDAQ:ABVC)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025